Secondly, this observation also suggests that loss of UCN1‐mediated inhibition of ERA and ERB, may lead to increased estrogen activity in endometrial cancer, thus promoting estrogen‐induced proliferation and migration. The gene discussed is ESR2; the disease is endometrial cancer.